Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BIOABioage Labs Inc
| 3.81% | $47.942M 2.305M shares@ $20.81 avg price | New Position |
INCYIncyte Corp
| 3.75% | $47.207M 714,176 shares@ $66.11 avg price | New Position |
NVSNovartis Ag
| 1.83% | $23.004M↓ Put 200,000 shares@ $115.02 avg price | New Position |
JAZZJazz Pharmaceuticals Plc
| 1.67% | $21.008M 188,562 shares@ $111.41 avg price | New Position |
RYTMRhythm Pharmaceuticals
| 1.16% | $14.495M 276,678 shares@ $52.39 avg price | New Position |
GHGuardant Health Inc
| 0.75% | $9.328M 406,645 shares@ $22.94 avg price | New Position |
JANXJanux Therapeutics Inc
| 0.6% | $7.486M 164,770 shares@ $45.43 avg price | New Position |
ILMNIllumina Inc
| 0.43% | $5.296M 40,611 shares@ $130.42 avg price | New Position |
BDXBecton Dickinson & Co
| 0.3% | $3.663M 15,191 shares@ $241.1 avg price | New Position |
TMOThermo Fisher Scientific Inc
| 0.29% | $3.569M 5,770 shares@ $618.58 avg price | New Position |